State Release 170
Guidance for : Collection of Medicaid Rebates for Certain Outpatient Orphan Drugs Dispensed by Certain 340B Entities We have received inquiries regarding the release issued by the Health Resources and Services Administration (HRSA) on February 13, 2015, (�February release�) of a list of manufacturers that are not providing 340B discounts to certain 340B entities on drugs that have orphan drug designations (when used for their non-orphan indications). We are providing this information to states
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: April 23, 2015
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.